News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Stephen Liu: Discussing Drug Development in RET and ROS1 Lung Cancer With Colleagues in China
Stephen Liu/LinkedIn
Jul 31, 2025, 14:26

Stephen Liu: Discussing Drug Development in RET and ROS1 Lung Cancer With Colleagues in China

Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics, shared a post on X:

“Early morning meeting to connect virtually with colleagues in China!

Discussed drug development in rare molecular subtypes including RET and ROS1 lung cancer and geographic differences in disease and research infrastructure.

Thanks to chairs Prof. Shun Lu, Li Zhang, and Ziming Li.”

Stephen Liu: Discussing Drug Development in RET and ROS1 Lung Cancer With Colleagues in China

More posts featuring Lung Cancer.

cancer drug development Li Zhang Lung cancer OncoDaily Oncology Shun Lu Stephen V Liu Ziming Li
Special Coverage
Blog
Jul 31, 2025, 14:26
Stephen Liu: Discussing Drug Development in RET and ROS1 Lung Cancer With Colleagues in China
Insight
Jul 31, 2025, 14:15
Paolo Tarantino: A Review of Rapidly Evolving Field of ADCs
Insight
Jul 31, 2025, 13:56
MRD Testing in Solid Tumors: Clinical Evidence and Coverage Challenges - Market Access 360 Insights
Blog
Jul 31, 2025, 13:54
Reem Al-Ajlouni: What if Saving Lives Also Saves the Economy?
Insight
Jul 31, 2025, 13:41
Pojsakorn Danpanichkul: The Role of AI in Heptocellular Carcinoma Detection
Blog
Jul 31, 2025, 13:39
Roupen Odabashian: How AI is Helping Democratize Scientific Communication
Insight
Jul 31, 2025, 13:34
Elena Castro: Germline Variants With Therapeutic Implications in Prostate Cancer
Blog
Jul 31, 2025, 13:20
Andrea Necchi: An Important Day for Patients with Bladder Cancer
Insight
Jul 31, 2025, 13:14
Ben Derman: Guideline on How to Think About Kidney Transplantation in Patients with Plasma Cell Disorders
Blog
Jul 31, 2025, 13:01
Anke Pregler: Financial Toxicity and The Right to Be Forgotten
Blog
Jul 31, 2025, 12:59
Naveen Pemmaraju: Right After My Annual BPDCN Update Leukemia
Blog
Jul 31, 2025, 12:53
Al-Ola A Abdallah: Our Newest Member at HMCT